| Style | Citing Format |
|---|---|
| MLA | Bagheri N, et al.. "Clinical Integration of 3-Dimensional Printing in Shoulder Surgery: Current Applications, Evidence, and Future Directions: A Narrative Review." JBJS reviews, vol. 14, no. 2, 2026, pp. -. |
| APA | Bagheri N, Guity M, Salkhori O, Kalantar SH, Khabiri SS, Mortazavi SM, Nezhad Tabrizi B, Naghizadeh H (2026). Clinical Integration of 3-Dimensional Printing in Shoulder Surgery: Current Applications, Evidence, and Future Directions: A Narrative Review. JBJS reviews, 14(2), -. |
| Chicago | Bagheri N, Guity M, Salkhori O, Kalantar SH, Khabiri SS, Mortazavi SM, Nezhad Tabrizi B, Naghizadeh H. "Clinical Integration of 3-Dimensional Printing in Shoulder Surgery: Current Applications, Evidence, and Future Directions: A Narrative Review." JBJS reviews 14, no. 2 (2026): -. |
| Harvard | Bagheri N et al. (2026) 'Clinical Integration of 3-Dimensional Printing in Shoulder Surgery: Current Applications, Evidence, and Future Directions: A Narrative Review', JBJS reviews, 14(2), pp. -. |
| Vancouver | Bagheri N, Guity M, Salkhori O, Kalantar SH, Khabiri SS, Mortazavi SM, et al.. Clinical Integration of 3-Dimensional Printing in Shoulder Surgery: Current Applications, Evidence, and Future Directions: A Narrative Review. JBJS reviews. 2026;14(2):-. |
| BibTex | @article{ author = {Bagheri N and Guity M and Salkhori O and Kalantar SH and Khabiri SS and Mortazavi SM and Nezhad Tabrizi B and Naghizadeh H}, title = {Clinical Integration of 3-Dimensional Printing in Shoulder Surgery: Current Applications, Evidence, and Future Directions: A Narrative Review}, journal = {JBJS reviews}, volume = {14}, number = {2}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Bagheri N AU - Guity M AU - Salkhori O AU - Kalantar SH AU - Khabiri SS AU - Mortazavi SM AU - Nezhad Tabrizi B AU - Naghizadeh H TI - Clinical Integration of 3-Dimensional Printing in Shoulder Surgery: Current Applications, Evidence, and Future Directions: A Narrative Review JO - JBJS reviews VL - 14 IS - 2 SP - EP - PY - 2026 ER - |